Literature DB >> 20823151

AACR special conference on epithelial-mesenchymal transition and cancer progression and treatment.

Evanthia T Roussos1, Zuzana Keckesova, John D Haley, David M Epstein, Robert A Weinberg, John S Condeelis.   

Abstract

Epithelial-mesenchymal transition (EMT) is a developmental program implicated in cancer progression and was the subject of the 2010 AACR meeting on the topic of EMT and Cancer Progression and Treatment held on February 28 to March 2 in Arlington, Virginia. A review of the involvement of EMT in gastrulation, organogenesis, carcinogenesis, and metastatic progression elucidated the overlap of EMT in these physiologic and pathologic conditions. Both novel and traditional markers of cells undergoing EMT were discussed and compared with features used to define cancer stem cells. Importantly, these defining characteristics of cells undergoing EMT were discussed in the context of therapeutic and prognostic developments.
© 2010 AACR.

Entities:  

Mesh:

Year:  2010        PMID: 20823151     DOI: 10.1158/0008-5472.CAN-10-1208

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  38 in total

1.  Induction and analysis of epithelial to mesenchymal transition.

Authors:  Yixin Tang; Greg Herr; Wade Johnson; Ernesto Resnik; Joy Aho
Journal:  J Vis Exp       Date:  2013-08-27       Impact factor: 1.355

2.  Epithelial-mesenchymal transition enhances response to oncolytic herpesviral therapy through nectin-1.

Authors:  Chun-Hao Chen; Wei-Yi Chen; Shu-Fu Lin; Richard J Wong
Journal:  Hum Gene Ther       Date:  2014-04-02       Impact factor: 5.695

3.  Cytoplasmic expression of Twist1, an EMT-related transcription factor, is associated with higher grades renal cell carcinomas and worse progression-free survival in clear cell renal cell carcinoma.

Authors:  Arezoo Rasti; Zahra Madjd; Maryam Abolhasani; Mitra Mehrazma; Leila Janani; Leili Saeednejad Zanjani; Mojgan Asgari
Journal:  Clin Exp Med       Date:  2017-12-04       Impact factor: 3.984

4.  Coxsackie-adenovirus receptor as a novel marker of stem cells in treatment-resistant non-small cell lung cancer.

Authors:  Xiaochun Zhang; Bingliang Fang; Radhe Mohan; Joe Y Chang
Journal:  Radiother Oncol       Date:  2012-09-27       Impact factor: 6.280

5.  Establishment of a highly migratory subclone reveals that CD133 contributes to migration and invasion through epithelial-mesenchymal transition in pancreatic cancer.

Authors:  Qiang Ding; Makoto Yoshimitsu; Taisaku Kuwahata; Koki Maeda; Tomomi Hayashi; Toru Obara; Yumi Miyazaki; Shyuichiro Matsubara; Shoji Natsugoe; Sonshin Takao
Journal:  Hum Cell       Date:  2011-11-23       Impact factor: 4.174

6.  Epithelial Mesenchymal Transition (EMT) in Metastatic Breast Cancer in Omani Women.

Authors:  Ritu Lakhtakia; Adil Aljarrah; Muhammad Furrukh; Shyam S Ganguly
Journal:  Cancer Microenviron       Date:  2017-05-19

Review 7.  The cancer stem cell niche--there goes the neighborhood?

Authors:  Stephanie M Cabarcas; Lesley A Mathews; William L Farrar
Journal:  Int J Cancer       Date:  2011-09-14       Impact factor: 7.396

8.  Special AT-rich sequence-binding protein 1 promotes cell growth and metastasis in colorectal cancer.

Authors:  Xue-Feng Fang; Zhi-Bo Hou; Xin-Zheng Dai; Cong Chen; Jing Ge; Hong Shen; Xiao-Feng Li; Li-Ke Yu; Ying Yuan
Journal:  World J Gastroenterol       Date:  2013-04-21       Impact factor: 5.742

9.  CXCR2 expression in tumor cells is a poor prognostic factor and promotes invasion and metastasis in lung adenocarcinoma.

Authors:  Pierre Saintigny; Erminia Massarelli; Steven Lin; Young-Ho Ahn; Yulong Chen; Sangeeta Goswami; Baruch Erez; Michael S O'Reilly; Diane Liu; J Jack Lee; Li Zhang; Yuan Ping; Carmen Behrens; Luisa M Solis Soto; John V Heymach; Edward S Kim; Roy S Herbst; Scott M Lippman; Ignacio I Wistuba; Waun Ki Hong; Jonathan M Kurie; Ja Seok Koo
Journal:  Cancer Res       Date:  2012-11-30       Impact factor: 12.701

Review 10.  Targeting adaptive glioblastoma: an overview of proliferation and invasion.

Authors:  Qian Xie; Sandeep Mittal; Michael E Berens
Journal:  Neuro Oncol       Date:  2014-07-30       Impact factor: 12.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.